首页 | 本学科首页   官方微博 | 高级检索  
   检索      


A novel mutant PIK3R1EY451delinsD breast cancer patient resistant to HER2-targeted therapy treated with everolimus: a case report
Authors:Wang  Kainan  Hu  Ye  Xu  Lingzhi  Zhao  Shanshan  Song  Chen  Sun  Siwen  Li  Xuelu  Li  Man
Institution:1.Department of Oncology & Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, 116023, Liaoning Province, China
;
Abstract:Molecular Biology Reports - Resistance to HER2-targeted therapy is a critical issue in breast cancer that must be addressed immediately. PIK3R1 mutations are more common in Chinese breast cancer...
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号